Category / research integrity

Researcher Roadshow – Exploring Health Data Science

Researcher Roadshow
Exploring Health Data Science

March 1st, 2023. 10:00 – 12:00

The NIHR Research Design Service, Health Data Research UK (HDR UK), the MRC Regulatory Support Centre and NHS Digital are pleased to offer the opportunity to attend the sixth in a series of virtual researcher roadshows.

This free to attend event is aimed at researchers and others working with health and social care datasets who would like to increase their understanding of roles of health data scientists and value of health data science.

The event will bring together health data scientists from the NHS, academia, and industry and provide insights and perspectives on the important work they do.

This event will include presentations on different roles and careers in health data science and different methods and approaches used by health data scientists.

Speakers will be confirmed in the New Year. 

Provisional registration is at: https://ukri.zoom.us/webinar/register/WN_GntzbzTITLmw0ghBRadQKQ


Recordings of previous Researcher Roadshows can be viewed here – Research Advisory Group (RAG) researcher roadshows – NHS Digital


Queries: If you have any questions about this event, please contact: rsc@mrc.ukri.org

Introduction to Patient and Public Involvement (PPI) for Researchers – free event

Introduction to Patient and Public Involvement (PPI) for Researchers

Date: Tuesday 10 January 2023
Time: 10:30 – 12:30

This event is aimed at people who are new to PPI or setting up their first PPI project, and is free for students and staff from the NIHR, NHS, UK universities, public sector institutions and registered charities based in the UK.

It will help them to discover the support available to plan, deliver and build PPI into their research, and highlight how PPI improves research for patients, services users and carers.

Free online course – Improving Healthcare Through Clinical Research

Interested in clinical research and what’s involved? Are you contemplating a career in healthcare or the life sciences, or, do you want to find out more about the role of clinical research in improving healthcare?

If you’ve answered yes to any of the above questions, then why not sign up to FutureLearn’s Improving Healthcare Through Clinical Research course?

The course has been developed by the University of Leeds and is be available now, via this link.

It is completely free and all online, lasting 4 weeks.

This course has been certified by the CPD Certification Service as conforming to continuing professional development principles. By completing the course you will have achieved 16 hours of CPD time.

Remember – support is on offer at BU if you are thinking of introducing your research ideas into the NHS – email the  Clinical Research mailbox, and take a look at the Clinical Governance website.

BU Ageing and Dementia Research Forum

We are developing a forum for those interested in ageing and dementia research at Bournemouth University. The forum is an opportunity to get together to chat about research and share experiences in a safe and supportive environment. Specific topics will be discussed but there will also be time for open discussion to mull over aspects of research such as project ideas and planning, ethical considerations and patient and public involvement.

The next forum meetings will be in October and November (see table below), if you would like to join us, please email adrc@bournemouth.ac.uk so we can send you the meeting details.

Date, time, and campus    Research areas
27th October 2022

15.30-17.00

Talbot Campus

Dr Michele Board – Frailty

Dr Susan Dewhurst – Falls prevention

24th November 2022

15.30-17.00

Lansdowne Campus

Dorset Healthcare – Down syndrome and dementia

If you would like to discuss your research ideas at a future meeting, please email Michelle mheward@bournemouth.ac.uk

 

Could you help the Health Research Authority improve the research ethics review?

Remember – support is on offer at BU if you are thinking of introducing your research ideas into the NHS or social care – email the Clinical Research mailbox, and take a look at the Clinical Governance section of the website.

Trusted Research – information now live

Within the Research Environment pages on the BU website, there is now a section on the Trusted Research agenda.

The Trusted Research Agenda is a government initiative to secure the integrity of the system of international research collaboration and innovation.

Please visit the page to find out more, including key details and guidance.

RKEDF Clinical Research Governance Sessions

As you will be aware, RDS offers something called the RKEDF, or Research & Knowledge Exchange Development Framework – as part of this there are a number of sessions available surrounding clinical research governance. These sessions can be booked as a 1:2:1 or in bespoke group sessions with Suzy Wignall, BU’s Clinical Governance Advisor.

As always, general chats/specific discussions can also be booked in too – please just email!

The RKEDF sessions available are as follows:

Please get in touch if you are interested in any of these sessions.

For general guidance, documents and further information surrounding processes, take a look at the Clinical Governance website.

Panel recruitment: EoI for Deputy Chair (Science, Technology & Health Panel)

Research EthicsExpressions of interest are invited from members of the Professoriate, for the prestigious and honorary role of Deputy Chair, Science Technology Research Ethics Panel. The central research ethics panels work across the University to champion the highest ethical standards in research undertaken by staff and students (PGR).

This document provides further information about the role and the application process. The opportunity is open to Professors and Associate Professors.

Expressions of interest should consist of a CV and brief statement outlining your suitability for the role. These should be submitted to the RDS (researchethics@bournemouth.ac.uk) by 5pm on Friday 1 July 2022.

For an informal discussion about the role please contact:

– Prof Sam Porter, Chair of the Science, Technology and Health Ethics Panel

If you have any questions regarding the process, please email Sarah Bell or Suzy Wignall by email to researchethics@bournemouth.ac.uk.

Integrity week 16 – 20 May 2022

A reminder that we still have space on our research integrity events taking place this week:

  • Wednesday 18 May at 3 pm in the CREATE Lecture Theatre, Fusion Building, Talbot Campus – join Tim Clavert and the library team to consider Publications, open access and data.  Booking via Eventbrite
  • Thursday 19 May at 10.30 pm join online (only) – Fay Sweeting and Emily Bird who will be discussing their research with the Police.  Booking via Eventbrite
  • Thursday 19 May at 3 pm in FG06, Fusion Building, Talbot Campus – join Dr Sue Sudbury and Jess Ruddock for a workshop on ‘Practice Research Case Studies of Dorset Food Bank & Dorset Police’.  Booking via Eventbrite.
  • Friday 20 May at 10.30 am and again at 3.30 pm in the CREATE Lecture Theatre, Fusion Building, Talbot Campus – join Dr Huseyin Dogan for two separate sessions considering Diversity, Accessibility & Inclusivity.  Booking via Eventbrite.

 

Research Integrity Week – starting next week

Come join us next week, for an exciting series of keynote speakers and bespoke workshops discussing many subjects under the theme of research integrity.

We start the week of events with a talk by James Parry, Chief Executive of UK Research integrity Office (UKRIO).

UKRIO is an independent charity, offering support to the public, researchers and organisations to further good practice in academic, scientific and medical research. They promote integrity and high ethical standards in research, as well as robust and fair methods to address poor practice and misconduct. They pursue these aims through their publications on research practice, in-depth support and services for research employers, their education and training activities, and by providing expert guidance in response to requests for assistance from individuals and organisations.

Established in 2006, their aims are to:

  • Promote the good governance, management and conduct of academic, scientific and medical research.
  • Share good practice on how to address poor practice, misconduct and unethical behaviour.
  • Give confidential, independent and expert advice on specific research projects, cases, problems and issues.

James directs UKRIO’s work programme and leads its advisory service, responding to queries and concerns about research practice from researchers and the public.

Join us online or in person on Monday 16 May 2022 at 10.30 am.

You can register your place here via Eventbrite.

Elsevier-UK Institutions Agreement

Elsevier and Jisc have established an agreement to enable continued reading access for UK researchers and to enable open access publishing. When publishing in eligible Elsevier journals, authors will be able to choose to publish open access at no additional cost to the author.

This agreement is effective until the end of December 2024.

This agreement supports corresponding authors affiliated with a Jisc participating institution (which BU is), regardless of the department in which they work.

Authors who publish under this agreement can:

  • Publish their peer-reviewed research open access in hybrid journals, at no charge to the author.
  • Publish their peer-reviewed research in fully gold open access journals at a discount on the list price APC.
  • Publish eligible articles in a wide variety of participating Elsevier journals across disciplines.
  • Rely on high-quality peer-review and experienced editorial support.

You can search for whether the intended journal falls under the agreement here.

Eligibility criteria

  • The author must be the submitting corresponding author affiliated with an eligible institution
  • Articles must have an acceptance date between 1.1.2022 and 31.12.2024

Instructions for corresponding authors

  • Once your article has been accepted for publication in a participating journal, you will receive an email containing a link to the “post-acceptance author journey”. Upon selecting your publishing options, your affiliation will be validated by your institution, and you will be informed if the APC will be covered by the agreement.
  • Upon publication, your final published open access article will be made freely available on ScienceDirect, the world’s largest publishing platform.

Other open access publishing options for authors

Authors can continue to choose to publish under the subscription model and self-archive their manuscript (Green Open Access) in line with Elsevier’s sharing policy.


Details of this agreement and others which BU holds with publishers such as Wiley and Springer, can be found here. Any queries, please contact openaccess@bournemouth.ac.uk

Elsevier-UK Institutions Agreement

Elsevier and Jisc have established an agreement to enable continued reading access for UK researchers and to enable open access publishing. When publishing in eligible Elsevier journals, authors will be able to choose to publish open access at no additional cost to the author.

This agreement is effective until the end of December 2024.

This agreement supports corresponding authors affiliated with a Jisc participating institution (which BU is), regardless of the department in which they work.

Authors who publish under this agreement can:

  • Publish their peer-reviewed research open access in hybrid journals, at no charge to the author.
  • Publish their peer-reviewed research in fully gold open access journals at a discount on the list price APC.
  • Publish eligible articles in a wide variety of participating Elsevier journals across disciplines.
  • Rely on high-quality peer-review and experienced editorial support.

You can search for whether the intended journal falls under the agreement here.

Eligibility criteria

  • The author must be the submitting corresponding author affiliated with an eligible institution
  • Articles must have an acceptance date between 1.1.2022 and 31.12.2024

Instructions for corresponding authors

  • Once your article has been accepted for publication in a participating journal, you will receive an email containing a link to the “post-acceptance author journey”. Upon selecting your publishing options, your affiliation will be validated by your institution, and you will be informed if the APC will be covered by the agreement.
  • Upon publication, your final published open access article will be made freely available on ScienceDirect, the world’s largest publishing platform.

Other open access publishing options for authors

Authors can continue to choose to publish under the subscription model and self-archive their manuscript (Green Open Access) in line with Elsevier’s sharing policy.


Details of this agreement and others which BU holds with publishers such as Wiley and Springer, can be found here. Any queries, please contact openaccess@bournemouth.ac.uk

Request for feedback – MHRA clinical trials consultation

The Medicines & Healthcare products Regulatory Agency (the MHRA) have launched a public consultation into clinical trials.

The aim of the consultation is to streamline approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public involvement.

There will be a 1 hour meeting on Monday 14th February at 1pm until 2pm, where you can offer your thoughts and feedback for BU’s institutional response.

If you wish to attend the meeting, please get in touch to be added to the invitation.

If you are unable to make the above time but wish to offer your thoughts, please email clinicalresearch@bournemouth.ac.uk to ensure your feedback is included.

Research Ethics @ BU

Research EthicsAll research undertaken by BU staff and students is subject to appropriate ethical reflection, leading to a formal ethics review as appropriate.

When is a formal ethics review appropriate?  It is not possible to produce a definitive list, but key examples include all research involving human participants, tissue or personal data, experimentation on animals, animal tissue, genetically modified organisms, research on sensitive issues, research that might have an impact on the environment or our cultural heritage.

An ethics opinion from an appropriate Reviewer must be obtained before you can commence any data collection activity.

  • For staff and PGRs (high risk) this will be provided by a Central Research Ethics Panel
  • For PGRs (low risk) this will be provided by an Ethics Champion (Department)
  • For UG/PGT students (high risk) this will be provided by an appropriate Ethics Programme Team
  • For UG/PGT students (low risk) this will be provided by the Named Supervisor.

Data collection activities should not start until you have received a Favourable Opinion and your checklist has been approved online.

What type of activity may not require a formal ethics review?  Examples include patient and public involvement (PPI) to inform future research, audit, course or service evaluation.  Please refer to the research ethics code of practice (specifically 5.1 and 5.5).

How to seek a formal ethics review

  • Complete the online ethics checklist and don’t forget if recruiting human participants to attach relevant supporting documents such as Participant Information Sheet (PI Sheet), Participant Agreement Form (PAF), a copy of the questionnaire, interview/focus group schedule including questions, recruitment materials such as a poster, social media posts etc – any material that a participant will read needs to be reviewed.

Key Resources

To conclude this week’s spotlight on research ethics, ‘Research cannot be rendered ethical by completing a one-off administrative task… researchers and evaluators need to work in an ethical way throughout the research process[1].’

As we discussed earlier this week, it is important to think of the ethics process as a ‘live’ issue.  Some key examples are given below:

  • The data. What have you collected; does it contain personal information/special category data?  Are your data management plans still relevant?
    • If collecting personal or special category data, you need to consider data minimisation. This means minimising the scope of the data (i.e. data fields) which are necessary for the research.  Steps include limiting the scope of the data collected, deleting data fields when no longer required, masking some data fields to reduce identification risk or fully anonymising data, setting access restrictions in respect of data in an identifiable form.
  • Wellbeing both physical and emotional. This is important when in the field, for you and your participants but also extends to the data analysis phase, particularly if reliving the discussion, which can be traumatic depending on the topic.
  • Planned aftercare: If recruiting participants what relationship might develop between you and your participants? How will the activities conclude and what would be appropriate participant aftercare?
  • Planned dissemination/outputs: could the results be misused by people with different agendas?
  • Ethics submission. It is your responsibility to ensure that where the scope of the research project changes, such changes are evaluated to ensure that the Favourable Opinion you have been issued remains appropriate.    If your agreed research protocol has changed, you should complete an Amendment Request Form before changes are implemented.

Help is always on hand

If you have a question related to research ethics, there are a few avenues where you can seek advice:

  • Students should contact their supervisor in the first instance
  • Staff can contact a member of the Research Ethics Panels for an informal chat.
  • You can also contact a member of the RDS Governance Team by emailing Research Ethics

[1] Helen Kara, 2018. Research Ethics in the real world, Policy Press

Request for feedback – MHRA clinical trials consultation

The Medicines & Healthcare products Regulatory Agency (the MHRA) have launched a public consultation into clinical trials.

The aim of the consultation is to streamline approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public involvement.

There will be a 1 hour meeting on Monday 14th February at 1pm until 2pm, where you can offer your thoughts and feedback for BU’s institutional response.

If you wish to attend the meeting, please get in touch to be added to the invitation.

If you are unable to make the above time but wish to offer your thoughts, please email clinicalresearch@bournemouth.ac.uk to ensure your feedback is included.